Image Guided Radiotherapy Market Forecasts to 2030 – Global Analysis By Product (Software, Hardware, Accessories and Service), Technology, Application, End User and By Geography

Image Guided Radiotherapy Market Forecasts to 2030 – Global Analysis By Product (Software, Hardware, Accessories and Service), Technology, Application, End User and By Geography


According to Stratistics MRC, the Global Image Guided Radiotherapy Market is accounted for $2.05 billion in 2023 and is expected to reach $3.34 billion by 2030 growing at a CAGR of 7.2% during the forecast period. Image Guided Radiotherapy (IGRT) is a precise form of radiation therapy that utilizes imaging technology to guide the delivery of radiation to tumours. IGRT enables clinicians to visualize the tumor and surrounding tissues in real-time, allowing for more accurate targeting of radiation and minimizing damage to healthy tissue. This approach enhances treatment effectiveness while reducing side effects. IGRT is particularly valuable for tumours that move during treatment or are located near critical organs, offering improved outcomes and increased patient safety.

According to the American Cancer Society, the burden of cancer worldwide is expected to reach ~28.4 million cases by 2040, increased by 47% from 2020, with greater increases in developing countries due to demographic changes and over 60% of cancer patients undergo some form of radiation therapy as part of their treatment.

Market Dynamics:

Driver:

Rising prevalence of cancer

With cancer incidence rates on the rise, there's an amplified demand for advanced treatment modalities that offer precision and minimal invasiveness. IGRT, leveraging cutting-edge imaging technologies, enables precise tumor targeting while sparing healthy tissues, making it an increasingly preferred option in oncology. This growing demand for more effective and tailored cancer treatments positions IGRT as a pivotal solution, driving its adoption and market growth amidst the expanding landscape of cancer care.

Restraint:

Lack of skilled professionals

The scarcity of trained professionals poses a significant obstacle to the expansion of the Image Guided Radiotherapy (IGRT) market. Successful utilization of IGRT technology necessitates skilled healthcare practitioners proficient in its operation and interpretation. Without an adequate workforce, healthcare facilities may struggle to offer IGRT services, leading to underutilization of IGRT technology and hindering its market growth potential.

Opportunity:

Continuous innovations in radiotherapy equipment

Continuous innovations in radiotherapy equipment enhance treatment precision, efficiency, and patient outcomes. Advanced features such as improved imaging modalities, real-time monitoring, and automated treatment delivery systems increase the accuracy of tumor targeting while minimizing damage to surrounding healthy tissue. These innovations attract healthcare providers seeking state-of-the-art solutions, boosting adoption rates. Additionally, technological advancements enable the development of more compact and cost-effective IGRT systems, expanding accessibility to a broader patient population.

Threat:

High cost of equipment and treatment

The high cost of equipment and treatment in IGRT limits accessibility, particularly in regions with constrained healthcare budgets. The substantial initial investment required for IGRT systems and ongoing treatment expenses can deter healthcare facilities from adopting this technology. Additionally, patients face financial burdens, and healthcare providers encounters challenges in securing reimbursement for IGRT procedures. Consequently, the high cost of equipment and treatment hampers the widespread adoption and utilization of IGRT, impeding market expansion.

Covid-19 Impact

The covid-19 pandemic has had a mixed impact on the image guided radiotherapy market. While it initially led to disruptions in treatment schedules and a slowdown in installations of new equipment due to healthcare facility closures and reprioritization of resources, there has been a subsequent rebound driven by pent-up demand and a growing emphasis on cancer care. Furthermore, the pandemic has accelerated the adoption of telemedicine and remote monitoring technologies, which could have long-term implications for how IGRT services are delivered and accessed, potentially fostering market growth.

The 3D ultrasound segment is expected to be the largest during the forecast period

The 3D ultrasound segment is estimated to have a lucrative growth. By providing real-time, high-resolution imaging of tumor sites, 3D ultrasound enhances the precision and accuracy of treatment delivery. This technology allows for better visualization of tumor boundaries and surrounding anatomy, enabling oncologists to tailor radiation therapy with utmost precision. Its incorporation into IGRT workflows enhances patient outcomes and treatment efficacy.

The brain tumours segment is expected to have the highest CAGR during the forecast period

The brain tumours segment is anticipated to witness the highest CAGR growth during the forecast period. Utilizing advanced imaging techniques such as MRI, CT, and PET scans, IGRT enables real-time visualization of tumours during treatment, allowing for accurate radiation delivery. This approach enhances treatment efficacy while reducing the risk of side effects. It also facilitates personalized treatment plans tailored to individual patient needs, optimizing outcomes for brain tumor patients.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to increasing cancer incidence and advancements in healthcare infrastructure. Emerging economies such as China and India are key contributors, supported by rising healthcare expenditure and expanding access to advanced treatment modalities. With a favourable regulatory environment and growing awareness about cancer care, the Asia Pacific IGRT market is poised for continued growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to high prevalence of cancer and robust healthcare infrastructure. The United States dominates the market, driven by extensive research and development activities, along with significant investments in healthcare technology. Increasing adoption of advanced imaging technologies and software solutions, coupled with favourable reimbursement policies, propels market expansion. With a focus on precision medicine and patient-centric care, the North American IGRT market is poised for sustained growth and technological advancements.

Key players in the market

Some of the key players profiled in the Image Guided Radiotherapy Market include Siemens Healthineers, Elekta AB, Accuray Incorporated, ViewRay, Inc., Brainlab AG, RaySearch Laboratories, Mevion Medical Systems, C-RAD AB, IBA Dosimetry GmbH, Philips Healthcare, Hitachi Medical Systems, Theragenics Corporation, Nanobiotix and Xstrahl Limited.

Key Developments:

In March 2024, Siemens Healthineers and Varian Medical Systems announced the launch of their Image Guided Radiotherapy (IGR) product. The product helps practitioners provide digital image data for diagnosis, risk stratification, and treatment planning in the early stages of liver cancer detection. The data can also provide guidance and support during care.

In February 2024, Royal Philips, a health technology company, announced the launch of the Azurion neuro biplane system, a new version of its Image Guided Therapy (IGT) platform. The Azurion platform is powered by ConnectOS, a new operating system from Philips that optimizes system integration.

Products Covered:
• Software
• Hardware
• Accessories
• Service

Technologies Covered:
• Cone Beam Computed Tomography (CBCT)
• 3D Ultrasound
• MRI-guided Radiation Therapy (MRI-RT)
• Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
• Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
• Other Technologies

Applications Covered:
• Prostate Cancer
• Breast Cancer
• Lung Cancer
• Head and Neck Cancer
• Brain Tumours
• Gynaecological Cancer
• Other Applications

End Users Covered:
• Hospitals
• Radiation Therapy Centers
• Cancer Research Institutes
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Image Guided Radiotherapy Market, By Product
5.1 Introduction
5.2 Software
5.2.1 Treatment Planning Software
5.2.2 Image Processing Software
5.2.3 Image Registration Software
5.2.4 Treatment Delivery Software
5.2.5 Quality Assurance Software
5.3 Hardware
5.3.1 Linear Accelerators (LINAC)
5.3.2 X-ray Systems
5.3.3 Ultrasound Systems
5.4 Accessories
5.4.1 IGRT Tables
5.4.2 IGRT Couches
5.4.3 IGRT Markers
5.4.4 IGRT Calibrators
5.4.5 IGRT Immobilization Devices
5.5 Service
5.5.1 Installation Services
5.5.2 Maintenance and Repair Services
6 Global Image Guided Radiotherapy Market, By Technology
6.1 Introduction
6.2 Cone Beam Computed Tomography (CBCT)
6.3 3D Ultrasound
6.4 MRI-guided Radiation Therapy (MRI-RT)
6.5 Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT)
6.6 Computed Tomography (CT) -guided Radiation Therapy (CT-RT)
6.7 Other Technologies
7 Global Image Guided Radiotherapy Market, By Application
7.1 Introduction
7.2 Prostate Cancer
7.3 Breast Cancer
7.4 Lung Cancer
7.5 Head and Neck Cancer
7.6 Brain Tumours
7.7 Gynaecological Cancer
7.8 Other Applications
8 Global Image Guided Radiotherapy Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Radiation Therapy Centers
8.4 Cancer Research Institutes
8.5 Other End Users
9 Global Image Guided Radiotherapy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Siemens Healthineers
11.2 Elekta AB
11.3 Accuray Incorporated
11.4 ViewRay, Inc.
11.5 Brainlab AG
11.6 RaySearch Laboratories
11.7 Mevion Medical Systems
11.8 C-RAD AB
11.9 IBA Dosimetry GmbH
11.10 Philips Healthcare
11.11 Hitachi Medical Systems
11.12 Theragenics Corporation
11.13 Nanobiotix
11.14 Xstrahl Limited
List of Tables
Table 1 Global Image Guided Radiotherapy Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Image Guided Radiotherapy Market Outlook, By Product (2021-2030) ($MN)
Table 3 Global Image Guided Radiotherapy Market Outlook, By Software (2021-2030) ($MN)
Table 4 Global Image Guided Radiotherapy Market Outlook, By Treatment Planning Software (2021-2030) ($MN)
Table 5 Global Image Guided Radiotherapy Market Outlook, By Image Processing Software (2021-2030) ($MN)
Table 6 Global Image Guided Radiotherapy Market Outlook, By Image Registration Software (2021-2030) ($MN)
Table 7 Global Image Guided Radiotherapy Market Outlook, By Treatment Delivery Software (2021-2030) ($MN)
Table 8 Global Image Guided Radiotherapy Market Outlook, By Quality Assurance Software (2021-2030) ($MN)
Table 9 Global Image Guided Radiotherapy Market Outlook, By Hardware (2021-2030) ($MN)
Table 10 Global Image Guided Radiotherapy Market Outlook, By Linear Accelerators (LINAC) (2021-2030) ($MN)
Table 11 Global Image Guided Radiotherapy Market Outlook, By X-ray Systems (2021-2030) ($MN)
Table 12 Global Image Guided Radiotherapy Market Outlook, By Ultrasound Systems (2021-2030) ($MN)
Table 13 Global Image Guided Radiotherapy Market Outlook, By Accessories (2021-2030) ($MN)
Table 14 Global Image Guided Radiotherapy Market Outlook, By IGRT Tables (2021-2030) ($MN)
Table 15 Global Image Guided Radiotherapy Market Outlook, By IGRT Couches (2021-2030) ($MN)
Table 16 Global Image Guided Radiotherapy Market Outlook, By IGRT Markers (2021-2030) ($MN)
Table 17 Global Image Guided Radiotherapy Market Outlook, By IGRT Calibrators (2021-2030) ($MN)
Table 18 Global Image Guided Radiotherapy Market Outlook, By IGRT Immobilization Devices (2021-2030) ($MN)
Table 19 Global Image Guided Radiotherapy Market Outlook, By Service (2021-2030) ($MN)
Table 20 Global Image Guided Radiotherapy Market Outlook, By Installation Services (2021-2030) ($MN)
Table 21 Global Image Guided Radiotherapy Market Outlook, By Maintenance and Repair Services (2021-2030) ($MN)
Table 22 Global Image Guided Radiotherapy Market Outlook, By Technology (2021-2030) ($MN)
Table 23 Global Image Guided Radiotherapy Market Outlook, By Cone Beam Computed Tomography (CBCT) (2021-2030) ($MN)
Table 24 Global Image Guided Radiotherapy Market Outlook, By 3D Ultrasound (2021-2030) ($MN)
Table 25 Global Image Guided Radiotherapy Market Outlook, By MRI-guided Radiation Therapy (MRI-RT) (2021-2030) ($MN)
Table 26 Global Image Guided Radiotherapy Market Outlook, By Positron Emission Tomography (PET) -guided Radiation Therapy (PET-RT) (2021-2030) ($MN)
Table 27 Global Image Guided Radiotherapy Market Outlook, By Computed Tomography (CT) -guided Radiation Therapy (CT-RT) (2021-2030) ($MN)
Table 28 Global Image Guided Radiotherapy Market Outlook, By Other Technologies (2021-2030) ($MN)
Table 29 Global Image Guided Radiotherapy Market Outlook, By Application (2021-2030) ($MN)
Table 30 Global Image Guided Radiotherapy Market Outlook, By Prostate Cancer (2021-2030) ($MN)
Table 31 Global Image Guided Radiotherapy Market Outlook, By Breast Cancer (2021-2030) ($MN)
Table 32 Global Image Guided Radiotherapy Market Outlook, By Lung Cancer (2021-2030) ($MN)
Table 33 Global Image Guided Radiotherapy Market Outlook, By Head and Neck Cancer (2021-2030) ($MN)
Table 34 Global Image Guided Radiotherapy Market Outlook, By Brain Tumours (2021-2030) ($MN)
Table 35 Global Image Guided Radiotherapy Market Outlook, By Gynaecological Cancer (2021-2030) ($MN)
Table 36 Global Image Guided Radiotherapy Market Outlook, By Other Applications (2021-2030) ($MN)
Table 37 Global Image Guided Radiotherapy Market Outlook, By End User (2021-2030) ($MN)
Table 38 Global Image Guided Radiotherapy Market Outlook, By Hospitals (2021-2030) ($MN)
Table 39 Global Image Guided Radiotherapy Market Outlook, By Radiation Therapy Centers (2021-2030) ($MN)
Table 40 Global Image Guided Radiotherapy Market Outlook, By Cancer Research Institutes (2021-2030) ($MN)
Table 41 Global Image Guided Radiotherapy Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings